First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (GBP) | FBTRegistrer dig for at låse op for ratings |
Fondens performance | 30-04-2024 |
Vækst af 1.000 (DKK) | Avanceret graf |
Fond | - | 3,8 | -0,3 | 0,8 | -6,1 | |
+/-Kat | - | 6,9 | 12,4 | -0,5 | -3,7 | |
+/-Indeks | - | -3,1 | 2,7 | -9,4 | -14,1 | |
Kategori: Sektor - Bioteknologi, Aktier | ||||||
Kategoribenchmark: Morningstar Gbl Biotechnolo... |
Oversigt | ||
Closing Price 13-05-2024 | GBX 1467,20 | |
Kursændring 1 dag | 0,87% | |
Morningstar Kategori™ | Sektor - Bioteknologi, Aktier | |
Omsætning | 750 | |
Børs | LONDON STOCK EXCHANGE, THE | |
ISIN | IE00BL0L0H60 | |
Markedsværdi i alt (mio.) 13-05-2024 | USD 5,06 | |
Seneste TNA(mio.) 13-05-2024 | USD 5,06 | |
Løbende omkostning 01-01-2023 | 0,60% | |
Investeringsstrategi | Passiv |
Investeringsmålsætning: First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (GBP) | FBT |
The Fund seeks investment results that correspond generally to the price and yield (before the Fund’s fees and expenses) of an equity index called the NYSE Arca Biotechnology Index℠ (the “Index”). |
Returns | |||||||||||||
|
Management | ||
Manager navn Startdato | ||
Ikke oplyst af foreningen 27-05-2020 | ||
Startdato 27-05-2020 |
Annonce |
Kategoribenchmark | |
Fondens indeks | Morningstar indeks |
NYSE Arca Biotechnology TR USD | Morningstar Gbl Biotechnology NR USD |
Target Market | ||||||||||||||||||||
|
Formuefordeling First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (GBP) | FBT | 13-05-2024 |
|
|
Top 5 placeringer | Sektor | % |
Moderna Inc | Healthcare | 3,87 |
Corcept Therapeutics Inc | Healthcare | 3,80 |
Mettler-Toledo International Inc | Healthcare | 3,76 |
Amgen Inc | Healthcare | 3,74 |
BeiGene Ltd ADR | Healthcare | 3,72 |
Øget Mindsket Ny siden sidste portefølje | ||
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (GBP) | FBT |